Travere Therapeutics names new R&D head ahead of 2027 retirement

Go back to Travere Therapeutics names new R&D head ahead of 2027 retirement
(NASDAQ: TVTX) Delayed: 64.74 +1.26 (1.98%)
Previous Close $63.48    52 Week High
Open $64.51    52 Week Low
Day High $65.86    P/E N/A 
Day Low $63.84    EPS
Volume 1,384,698